LTC004

The human multidrug resistance protein 1 (hMRP1) transporter is implicated in cancer multidrug resistance as well as immune responses involving its physiologic substrate, glutathione (GSH)-conjugated leukotriene C₄ (LTC₄). LTC₄ binds a bipartite site on hMRP1, which a recent cryoelectron microscopy structure of LTC₄-bound bovine Mrp1 depicts as composed of a positively charged pocket and a hydrophobic (H) pocket that binds the GSH moiety and surrounds the fatty acid moiety, respectively, of LTC₄. Here, we show that single Ala and Leu substitutions of H-pocket hMRP1-Met¹⁰⁹³ have no effect on LTC₄ binding or transport. Estrone 3-sulfate transport is also unaffected, but both hMRP1-Met¹⁰⁹³ mutations eliminate estradiol glucuronide transport, demonstrating that these steroid conjugates have binding sites distinct from each other and from LTC₄. To eliminate LTC₄ transport by hMRP1, mutation of 3 H-pocket residues was required (W553/M1093/W1246A), indicating that H-pocket amino acids are key to the vastly different affinities of hMRP1 for LTC₄vs. GSH alone. Unlike organic anion transport, hMRP1-mediated drug resistance was more diminished by Ala than Leu substitution of Met¹⁰⁹³. Although our findings generally support a structure in which H-pocket residues bind the lipid tail of LTC₄, their critical and differential role in the transport of conjugated estrogens and anticancer drugs remains unexplained.-Conseil, G., Arama-Chayoth, M., Tsfadia, Y., Cole, S. P. C. Structure-guided probing of the leukotriene C₄ binding site in human multidrug resistance protein 1 (MRP1; ABCC1).